A detailed history of Advisor Net Financial, Inc transactions in Cel Sci Corp stock. As of the latest transaction made, Advisor Net Financial, Inc holds 2,949 shares of CVM stock, worth $707. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,949
Holding current value
$707
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 07, 2025

BUY
$0.24 - $0.45 $707 - $1,327
2,949 New
2,949 $0
Q4 2019

Feb 12, 2020

SELL
$6.71 - $9.55 $6 - $9
-1 Closed
0 $0
Q3 2019

Oct 23, 2019

BUY
$6.0 - $9.6 $6 - $9
1 New
1 $0

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $10.4M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.